{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:58:18Z","timestamp":1793620698126,"version":"4.5.0"},"reference-count":130,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Endocrine science remains underrepresented in European Union research programmes despite the fundamental role of hormone health in human well-being. Analysis of the CORDIS database reveals a persistent gap between the societal impact of endocrine disorders and their research prioritization. At national funding level, endocrine societies report limited or little attention of national research funding towards endocrinology. The EndoCompass project\u2014a joint initiative between the European Society of Endocrinology and the European Society of Paediatric Endocrinology\u2014aimed to identify and promote strategic research priorities in endocrine science to address critical hormone-related health challenges.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Research priorities were established through comprehensive analysis of the EU CORDIS database covering the Horizon 2020 framework period (2014-2020). Expert consultation in bone and calcium endocrinology was conducted to identify key research priorities, followed by broader stakeholder engagement including society members and patient advocacy groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Research priorities encompass primary hyperparathyroidism, chronic hypoparathyroidism, and rare calcium\u2013phosphate disorders. Key areas include bone as endocrine organ, bone mass acquisition, secondary osteoporosis, and skeletal dysplasias. Special emphasis is placed on cellular senescence, sex-specific differences in disease manifestation, and development of novel diagnostic tools for bone quality assessment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This component of the EndoCompass project provides an evidence-based roadmap for strategic research investment. This framework identifies crucial investigation areas into metabolic bone disease pathophysiology, prevention, and treatment strategies, ultimately aimed at reducing the burden of these disorders on individuals and society. The findings support the broader EndoCompass objective of aligning research funding with areas of highest potential impact in endocrine health.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf064","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:02:06Z","timestamp":1760691726000},"page":"ii23-ii34","source":"Crossref","is-referenced-by-count":5,"title":["EndoCompass project: research roadmap for calcium and bone endocrinology"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9338-831X","authenticated-orcid":false,"given":"Katharina","family":"J\u00e4hn-Rickert","sequence":"first","affiliation":[{"name":"Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf , 22529 Hamburg ,","place":["Germany"]},{"name":"Mildred Scheel Cancer Career Center Hamburg, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf , 20251 Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1694-6891","authenticated-orcid":false,"given":"Karin","family":"Zibar Tom\u0161i\u0107","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetology, University Hospital Centre Zagreb , Kispaticeva 12, 10000 Zagreb ,","place":["Croatia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9624-6296","authenticated-orcid":false,"given":"Athanasios D","family":"Anastasilakis","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, 424 Military General Hospital , 56429 Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4104-702X","authenticated-orcid":false,"given":"Jean-Philippe","family":"Bertocchio","sequence":"additional","affiliation":[{"name":"Thyroid-Endocrine Tumors Department, Pitie-Salp\u00eatri\u00e8re Hospital, Assistance Publique-H\u00f4pitaux de Paris , 75013 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8741-0592","authenticated-orcid":false,"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[{"name":"Institute of Endocrine and Metabolic Sciences, Vita-Salute San Raffaele University and IRCCS , 20132 Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6170-6398","authenticated-orcid":false,"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of W\u00fcrzburg , 97080 W\u00fcrzburg ,","place":["Germany"]},{"name":"Comprehensive Cancer Center Mainfranken, University of W\u00fcrzburg , 97080 W\u00fcrzburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0742-7595","authenticated-orcid":false,"given":"Moira Shang-Mei","family":"Cheung","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Great Ormond Street Hospital , London WC1N 3JH ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4397-4126","authenticated-orcid":false,"given":"Evelien","family":"Gevers","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London , London EC1M 6BQ ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5963-214X","authenticated-orcid":false,"given":"Neil","family":"Gittoes","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham , Birmingham B15 2GW ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4547-001X","authenticated-orcid":false,"given":"Outi","family":"M\u00e4kitie","sequence":"additional","affiliation":[{"name":"Children's Hospital, University of Helsinki and Helsinki University Hospital , 00014 Helsinki ,","place":["Finland"]},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, and Clinical Genetics, Karolinska University Hospital , SE-171 76 Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5524-2646","authenticated-orcid":false,"given":"Gabriel \u00c1ngel","family":"Martos-Moreno","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Endocrinology, Hospital Infantil Universitario Ni\u00f1o Jes\u00fas, Instituto de Investigaci\u00f3n La Princesa , 28009 Madrid ,","place":["Spain"]},{"name":"Department of Pediatrics, Universidad Aut\u00f3noma de Madrid , 28039 Madrid ,","place":["Spain"]},{"name":"CIBER Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n (CIBEROBN), Instituto de Salud Carlos III , 28029 Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1461-8437","authenticated-orcid":false,"given":"Petar","family":"Milovanovic","sequence":"additional","affiliation":[{"name":"Centre of Bone Biology, Institute of Anatomy, University of Belgrade, Faculty of Medicine , 11000 Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3551-594X","authenticated-orcid":false,"given":"Adalbert","family":"Raimann","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Centre of Growth, Medical University of Vienna , 1090 Vienna ,","place":["Austria"]},{"name":"Vienna Bone and Growth Centre , 1130 Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8670-425X","authenticated-orcid":false,"given":"Michaela","family":"Tencerova","sequence":"additional","affiliation":[{"name":"Molecular Physiology of Bone, Institute of Physiology of the Czech Academy of Sciences , 142 00 Prague 4 ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9582-1906","authenticated-orcid":false,"given":"Elena","family":"Tsourdi","sequence":"additional","affiliation":[{"name":"Department of Medicine III, Technische Universit\u00e4t Dresden , 01307 Dresden ,","place":["Germany"]},{"name":"Center for Healthy Aging, Technische Universit\u00e4t Dresden , 01062 Dresden ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0277-2533","authenticated-orcid":false,"given":"Annegreet G","family":"Vlug","sequence":"additional","affiliation":[{"name":"Centre for Bone Quality, Department of Endocrinology, Leiden University Medical Centre , 2300 RC Leiden ,","place":["The Netherlands"]},{"name":"Department of Internal Medicine, Jan Van Goyen Medical Center , 1075 HN Amsterdam ,","place":["The Netherlands"]},{"name":"Department of Internal Medicine, OLVG Hospital , 1091 AC Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4328-6304","authenticated-orcid":false,"given":"Wolfgang","family":"H\u00f6gler","sequence":"additional","affiliation":[{"name":"Centre for Growth and Osteology, Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz , 4040 Linz ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1994-4226","authenticated-orcid":false,"given":"Peter","family":"Kamenick\u00fd","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Service d\u2019Endocrinologie et des Maladies de la Reproduction, Centre de R\u00e9f\u00e9rence des Maladies du M\u00e9tabolisme du Calcium et du Phosphate, H\u00f4pital Bic\u00eatre, AP-HP , 94276 Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"2","key":"2025101705020294400_lvaf064-B1","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/EJE-21-1044","article-title":"European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders","volume":"186","author":"Bollerslev","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2025101705020294400_lvaf064-B2","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2025101705020294400_lvaf064-B3","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1210\/clinem\/dgaa113","article-title":"Hypoparathyroidism","volume":"105","author":"Bilezikian","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2025101705020294400_lvaf064-B4","doi-asserted-by":"publisher","volume-title":"Calcium and Bone Disorders in Children and Adolescents","author":"SKarger","DOI":"10.1159\/isbn.978-3-318-05467-5"},{"key":"2025101705020294400_lvaf064-B5","doi-asserted-by":"publisher","first-page":"100057","DOI":"10.1016\/j.jposna.2024.100057","article-title":"Rare genetic skeletal disorders: evolving terminology, therapies, education and advocacy","volume":"7","author":"Tosi","year":"2024","journal-title":"J Pediatr Orthop Soc North Am"},{"issue":"1","key":"2025101705020294400_lvaf064-B6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.otc.2023.07.012","article-title":"Surgery for normocalcemic hyperparathyroidism","volume":"57","author":"Kulkarni","year":"2024","journal-title":"Otolaryngol Clin North Am"},{"issue":"11","key":"2025101705020294400_lvaf064-B7","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/jbmr.4682","article-title":"Management of primary hyperparathyroidism","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025101705020294400_lvaf064-B8","doi-asserted-by":"publisher","first-page":"e1171\u2013","DOI":"10.1210\/clinem\/dgaa084","article-title":"Normocalcemic hyperparathyroidism: study of its prevalence and natural history","volume":"105","author":"Schini","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"2025101705020294400_lvaf064-B9","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.3390\/jcm12196321","article-title":"Primary hyperparathyroidism in older adults: a narrative review of the most recent literature on epidemiology, diagnosis and management","volume":"12","author":"Rizk","year":"2023","journal-title":"J Clin Med"},{"issue":"11","key":"2025101705020294400_lvaf064-B10","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism","volume":"37","author":"Minisola","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"13","key":"2025101705020294400_lvaf064-B11","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.3390\/jcm10132956","article-title":"Primary hyperparathyroidism in pregnancy: literature review of the diagnosis and management","volume":"10","author":"Ali","year":"2021","journal-title":"J Clin Med"},{"issue":"18","key":"2025101705020294400_lvaf064-B12","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJMcp1800213","article-title":"Hypoparathyroidism","volume":"380","author":"Gafni","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"2025101705020294400_lvaf064-B13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ecl.2018.07.004","article-title":"Epidemiology and complications of hypoparathyroidism","volume":"47","author":"Clarke","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2025101705020294400_lvaf064-B14","volume-title":"Endotext","author":"Bastepe","year":"8, 2024","edition":"eds"},{"issue":"9","key":"2025101705020294400_lvaf064-B15","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025101705020294400_lvaf064-B16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"2025101705020294400_lvaf064-B17","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1002\/jbmr.4716","article-title":"Management of hypoparathyroidism","volume":"37","author":"Khan","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2025101705020294400_lvaf064-B18","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1210\/clinem\/dgae121","article-title":"An open-label phase 2 study of eneboparatide, a novel PTH receptor 1 agonist, in hypoparathyroidism","volume":"109","author":"Takacs","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"10232","key":"2025101705020294400_lvaf064-B19","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/S0140-6736(20)30538-9","article-title":"Treating hypoparathyroidism with recombinant human parathyroid hormone (1-34): long-term safety concerns","volume":"395","author":"Goujard","year":"2020","journal-title":"Lancet"},{"issue":"10205","key":"2025101705020294400_lvaf064-B20","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/S0140-6736(19)31334-0","article-title":"Advances in beta-cell replacement therapy for the treatment of type 1 diabetes","volume":"394","author":"Vantyghem","year":"2019","journal-title":"Lancet"},{"issue":"20","key":"2025101705020294400_lvaf064-B21","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1056\/NEJMoa2312665","article-title":"The role of interferon-gamma in autoimmune polyendocrine syndrome type 1","volume":"390","author":"Oikonomou","year":"2024","journal-title":"N Engl J Med"},{"key":"2025101705020294400_lvaf064-B22","first-page":"334","volume-title":"Encyclopedia of Endocrine Diseases","author":"Uday","year":"2019"},{"issue":"7","key":"2025101705020294400_lvaf064-B23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"2025101705020294400_lvaf064-B24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","article-title":"Diagnosis and management of pseudohypoparathyroidism and related disorders: first international consensus statement","volume":"14","author":"Mantovani","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"13","key":"2025101705020294400_lvaf064-B25","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1056\/NEJMc2302708","article-title":"Efficacy and safety of encaleret in autosomal dominant hypocalcemia type 1","volume":"389","author":"Gafni","year":"2023","journal-title":"N Engl J Med"},{"issue":"44","key":"2025101705020294400_lvaf064-B26","doi-asserted-by":"publisher","first-page":"eabj5018","DOI":"10.1126\/sciadv.abj5018","article-title":"A novel therapeutic strategy for skeletal disorders: proof of concept of gene therapy for X-linked hypophosphatemia","volume":"7","author":"Zhukouskaya","year":"2021","journal-title":"Sci Adv"},{"issue":"1","key":"2025101705020294400_lvaf064-B27","doi-asserted-by":"publisher","first-page":"e10709","DOI":"10.1002\/jbm4.10709","article-title":"Gene therapy using recombinant AAV type 8 vector encoding TNAP-D10 improves the skeletal phenotypes in murine models of osteomalacia","volume":"7","author":"Amadeu de Oliveira","year":"2022","journal-title":"JBMR Plus"},{"issue":"4","key":"2025101705020294400_lvaf064-B28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/biomedicines5040062","article-title":"Muscle-bone crosstalk: emerging opportunities for novel therapeutic approaches to treat musculoskeletal pathologies","volume":"5","author":"Maurel","year":"2017","journal-title":"Biomedicines"},{"issue":"4","key":"2025101705020294400_lvaf064-B29","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11914-020-00599-y","article-title":"Muscle, bone, and fat crosstalk: the biological role of myokines, osteokines, and adipokines","volume":"18","author":"Kirk","year":"2020","journal-title":"Curr Osteoporos Rep"},{"issue":"16","key":"2025101705020294400_lvaf064-B30","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"2025101705020294400_lvaf064-B31","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s40265-018-0905-7","article-title":"Burosumab: first global approval","volume":"78","author":"Lamb","year":"2018","journal-title":"Drugs"},{"issue":"4","key":"2025101705020294400_lvaf064-B32","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jamacardio.2018.0139","article-title":"Association of fibroblast growth factor 23 with risk of incident coronary heart disease in community-living adults","volume":"3","author":"Panwar","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"1","key":"2025101705020294400_lvaf064-B33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","article-title":"Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial","volume":"132","author":"Moe","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"2025101705020294400_lvaf064-B34","doi-asserted-by":"publisher","first-page":"e0213321","DOI":"10.1371\/journal.pone.0213321","article-title":"Circulating fibroblast growth factor 23 levels and incident dementia: the Framingham Heart Study","volume":"14","author":"McGrath","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"2025101705020294400_lvaf064-B35","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1210\/er.2012-1026","article-title":"The osteocyte: an endocrine cell \u2026 and more","volume":"34","author":"Dallas","year":"2013","journal-title":"Endocr Rev"},{"issue":"12","key":"2025101705020294400_lvaf064-B36","doi-asserted-by":"publisher","first-page":"e2100113","DOI":"10.1002\/adhm.202100113","article-title":"3D interrelationship between osteocyte network and forming mineral during human bone remodeling","volume":"10","author":"Ayoubi","year":"2021","journal-title":"Adv Healthc Mater"},{"issue":"8","key":"2025101705020294400_lvaf064-B37","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/jbmr.1927","article-title":"Architecture of the osteocyte network correlates with bone material quality","volume":"28","author":"Kerschnitzki","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2025101705020294400_lvaf064-B38","doi-asserted-by":"publisher","first-page":"7542","DOI":"10.1021\/nn401360u","article-title":"Osteocytic canalicular networks: morphological implications for altered mechanosensitivity","volume":"7","author":"Milovanovic","year":"2013","journal-title":"ACS Nano"},{"issue":"6","key":"2025101705020294400_lvaf064-B39","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/j.1474-9726.2010.00633.x","article-title":"Decrease in the osteocyte lacunar density accompanied by hypermineralized lacunar occlusion reveals failure and delay of remodeling in aged human bone","volume":"9","author":"Busse","year":"2010","journal-title":"Aging Cell"},{"issue":"2","key":"2025101705020294400_lvaf064-B40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jocd.2014.01.005","article-title":"Bone health in children and adolescents with chronic diseases that may affect the skeleton: the 2013 ISCD pediatric official positions","volume":"17","author":"Bianchi","year":"2014","journal-title":"J Clin Densitom"},{"issue":"2","key":"2025101705020294400_lvaf064-B41","doi-asserted-by":"publisher","first-page":"101616","DOI":"10.1016\/j.beem.2022.101616","article-title":"Acquisition of peak bone mass","volume":"36","author":"Chevalley","year":"2022","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"Supplement_2","key":"2025101705020294400_lvaf064-B42","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1542\/peds.2006-2023D","article-title":"Childhood bone mass acquisition and peak bone mass may not be important determinants of bone mass in late adulthood","volume":"119","author":"Gafni","year":"2007","journal-title":"Pediatrics"},{"issue":"6","key":"2025101705020294400_lvaf064-B43","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s11914-023-00822-6","article-title":"Bone material properties in bone diseases affecting children","volume":"21","author":"Raimann","year":"2023","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"2025101705020294400_lvaf064-B44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/MED.0000000000000849","article-title":"Bone mass accrual in children","volume":"31","author":"Rodrick","year":"2024","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2025101705020294400_lvaf064-B45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000381045","article-title":"Osteoporosis in children with chronic disease","volume":"28","author":"H\u00f6gler","year":"2015","journal-title":"Endocr Dev"},{"issue":"5-6","key":"2025101705020294400_lvaf064-B46","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s10354-020-00741-6","article-title":"New developments in the management of achondroplasia","volume":"170","author":"H\u00f6gler","year":"2020","journal-title":"Wien Med Wochenschr"},{"issue":"2","key":"2025101705020294400_lvaf064-B47","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1210\/clinem\/dgae507","article-title":"Approach to the pediatric patient with glucocorticoid-induced osteoporosis","volume":"110","author":"Ward","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025101705020294400_lvaf064-B48","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/endrev\/bnab028","article-title":"Secondary osteoporosis","volume":"43","author":"Ebeling","year":"2022","journal-title":"Endocr Rev"},{"issue":"2","key":"2025101705020294400_lvaf064-B49","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jbmr.556","article-title":"FRAX underestimates fracture risk in patients with diabetes","volume":"27","author":"Giangregorio","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2025101705020294400_lvaf064-B50","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1007\/s00198-011-1713-z","article-title":"Interpretation and use of FRAX in clinical practice","volume":"22","author":"Kanis","year":"2011","journal-title":"Osteoporos Int"},{"issue":"2","key":"2025101705020294400_lvaf064-B51","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s00223-016-0191-x","article-title":"DXA-based measurements in diabetes: can they predict fracture risk?","volume":"100","author":"Schacter","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"2025101705020294400_lvaf064-B52","doi-asserted-by":"publisher","first-page":"115457","DOI":"10.1016\/j.bone.2020.115457","article-title":"The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: a systematic review and meta-analysis update","volume":"137","author":"Vilaca","year":"2020","journal-title":"Bone"},{"issue":"2","key":"2025101705020294400_lvaf064-B53","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/jbmr.4466","article-title":"Greater carboxy-methyl-lysine is associated with increased fracture risk in type 2 diabetes","volume":"37","author":"Dhaliwal","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2025101705020294400_lvaf064-B54","doi-asserted-by":"publisher","first-page":"115556","DOI":"10.1016\/j.bone.2020.115556","article-title":"Individuals with type 2 diabetes mellitus show dimorphic and heterogeneous patterns of loss in femoral bone quality","volume":"140","author":"W\u00f6lfel","year":"2020","journal-title":"Bone"},{"key":"2025101705020294400_lvaf064-B55","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.actbio.2023.02.037","article-title":"Osteocyte apoptosis and cellular micropetrosis signify skeletal aging in type 1 diabetes","volume":"162","author":"Kolibova","year":"2023","journal-title":"Acta Biomater"},{"issue":"3","key":"2025101705020294400_lvaf064-B56","doi-asserted-by":"publisher","first-page":"ziae005","DOI":"10.1093\/jbmrpl\/ziae005","article-title":"Lower microhardness along with less heterogeneous mineralization in the femoral neck of individuals with type 2 diabetes mellitus indicates higher fracture risk","volume":"8","author":"Cirovic","year":"2024","journal-title":"JBMR Plus"},{"issue":"1","key":"2025101705020294400_lvaf064-B57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00223-021-00894-5","article-title":"Vascular complications in individuals with type 2 diabetes mellitus additionally increase the risk of femoral neck fractures due to deteriorated trabecular microarchitecture","volume":"110","author":"Cirovic","year":"2022","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"2025101705020294400_lvaf064-B58","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1210\/er.2015-1106","article-title":"Role of thyroid hormones in skeletal development and bone maintenance","volume":"37","author":"Bassett","year":"2016","journal-title":"Endocr Rev"},{"issue":"6","key":"2025101705020294400_lvaf064-B59","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1089\/105072503322238854","article-title":"Hyperthyroidism, bone mineral, and fracture risk\u2013a meta-analysis","volume":"13","author":"Vestergaard","year":"2003","journal-title":"Thyroid"},{"issue":"3","key":"2025101705020294400_lvaf064-B60","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1530\/JOE-12-0059","article-title":"The skeletal consequences of thyrotoxicosis","volume":"213","author":"Nicholls","year":"2012","journal-title":"J Endocrinol"},{"issue":"(06\/07|6\/07)","key":"2025101705020294400_lvaf064-B61","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1055\/a-1088-1215","article-title":"Thyroid hormone actions and bone remodeling\u2014the role of the Wnt signaling pathway","volume":"128","author":"Lademann","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"2025101705020294400_lvaf064-B62","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00418-022-02128-7","article-title":"Micro-scale assessment of bone quality changes in adult cadaveric men with congestive hepatopathy","volume":"158","author":"Jadzic","year":"2022","journal-title":"Histochem Cell Biol"},{"issue":"1","key":"2025101705020294400_lvaf064-B63","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40618-023-02130-3","article-title":"Micro-scale vertebral features in postmenopausal women with alcohol-associated and metabolic-associated fatty liver disease: ex vivo bone quality analyses","volume":"47","author":"Jadzic","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2025101705020294400_lvaf064-B64","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/jbmr.3410","article-title":"Disease duration and stage influence bone microstructure in patients with primary biliary cholangitis","volume":"33","author":"Schmidt","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2025101705020294400_lvaf064-B65","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/joa.13621","article-title":"The altered osteocytic expression of connexin 43 and sclerostin in human cadaveric donors with alcoholic liver cirrhosis: potential treatment targets","volume":"240","author":"Jadzic","year":"2022","journal-title":"J Anat"},{"key":"2025101705020294400_lvaf064-B66","doi-asserted-by":"publisher","first-page":"116020","DOI":"10.1016\/j.bone.2021.116020","article-title":"Mechano-structural alteration in proximal femora of individuals with alcoholic liver disease: implications for increased bone fragility","volume":"150","author":"Jadzic","year":"2021","journal-title":"Bone"},{"issue":"3","key":"2025101705020294400_lvaf064-B67","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/MPG.0b013e31823e9412","article-title":"Endocrine and bone metabolic complications in chronic liver disease and after liver transplantation in children","volume":"54","author":"H\u00f6gler","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"9","key":"2025101705020294400_lvaf064-B68","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.3390\/jcm11092382","article-title":"Secondary osteoporosis and metabolic bone diseases","volume":"11","author":"Sobh","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"2025101705020294400_lvaf064-B69","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40520-021-01823-0","article-title":"Management of glucocorticoid-induced osteoporosis","volume":"33","author":"Messina","year":"2021","journal-title":"Aging Clin Exp Res"},{"issue":"15","key":"2025101705020294400_lvaf064-B70","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1097\/MD.0000000000000647","article-title":"Monitoring of patients on long-term glucocorticoid therapy: a population-based cohort study","volume":"94","author":"Fardet","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2025101705020294400_lvaf064-B71","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMcp1012926","article-title":"Clinical practice. Glucocorticoid-induced bone disease","volume":"365","author":"Weinstein","year":"2011","journal-title":"N Engl J Med"},{"issue":"3-4","key":"2025101705020294400_lvaf064-B72","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10495-020-01599-0","article-title":"Glucocorticoid-induced autophagy and apoptosis in bone","volume":"25","author":"Wang","year":"2020","journal-title":"Apoptosis"},{"issue":"4","key":"2025101705020294400_lvaf064-B73","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength","volume":"145","author":"O'Brien","year":"2004","journal-title":"Endocrinology"},{"issue":"7","key":"2025101705020294400_lvaf064-B74","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1530\/EC-19-0104","article-title":"Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans","volume":"8","author":"Thiele","year":"2019","journal-title":"Endocr Connect"},{"issue":"1","key":"2025101705020294400_lvaf064-B75","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0169-6009(91)90139-q","article-title":"Bone loss in response to long-term glucocorticoid therapy","volume":"8","author":"LoCascio","year":"1990","journal-title":"Bone Miner"},{"issue":"11","key":"2025101705020294400_lvaf064-B76","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1002\/art.11283","article-title":"Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy","volume":"48","author":"Van Staa","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"7","key":"2025101705020294400_lvaf064-B77","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/jbmr.3970","article-title":"Long-term immobilization in elderly females causes a specific pattern of cortical bone and osteocyte deterioration different from postmenopausal osteoporosis","volume":"35","author":"Rolvien","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025101705020294400_lvaf064-B78","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jocd.2019.07.002","article-title":"The utility of DXA assessment at the forearm, proximal femur, and lateral distal femur, and vertebral fracture assessment in the pediatric population: 2019 ISCD official position","volume":"22","author":"Weber","year":"2019","journal-title":"J Clin Densitom"},{"issue":"1","key":"2025101705020294400_lvaf064-B79","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1359\/JBMR.0301208","article-title":"Trabecular bone microarchitecture is deteriorated in men with spinal cord injury","volume":"19","author":"Modlesky","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2025101705020294400_lvaf064-B80","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.tem.2024.01.004","article-title":"A perspective on muscle phenotyping in musculoskeletal research","volume":"35","author":"Foessl","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"2025101705020294400_lvaf064-B81","volume-title":"StatPearls","author":"Ganesan","year":"2, 2023"},{"key":"2025101705020294400_lvaf064-B82","doi-asserted-by":"publisher","first-page":"709711","DOI":"10.3389\/fendo.2021.709711","article-title":"A roadmap to gene discoveries and novel therapies in monogenic low and high bone mass disorders","volume":"12","author":"Formosa","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025101705020294400_lvaf064-B83","doi-asserted-by":"publisher","first-page":"104936","DOI":"10.1016\/j.ejmg.2024.104936","article-title":"Osteopetrosis and related osteoclast disorders in adults: a review and knowledge gaps on behalf of the European calcified tissue society and ERN BOND","volume":"69","author":"Funck-Brentano","year":"2024","journal-title":"Eur J Med Genet"},{"issue":"12","key":"2025101705020294400_lvaf064-B84","doi-asserted-by":"publisher","first-page":"104868","DOI":"10.1016\/j.ejmg.2023.104868","article-title":"Data collection on rare bone and mineral conditions in Europe: the landscape of registries and databases","volume":"66","author":"Priego Zurita","year":"2023","journal-title":"Eur J Med Genet"},{"issue":"5","key":"2025101705020294400_lvaf064-B85","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/ajmg.a.63132","article-title":"Nosology of genetic skeletal disorders: 2023 revision","volume":"191","author":"Unger","year":"2023","journal-title":"Am J Med Genet A"},{"issue":"5","key":"2025101705020294400_lvaf064-B86","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"2025101705020294400_lvaf064-B87","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1530\/EJE-20-0299","article-title":"Osteogenesis imperfecta: an update on clinical features and therapies","volume":"183","author":"Marom","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2025101705020294400_lvaf064-B88","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1106173","article-title":"Enzyme-replacement therapy in life-threatening hypophosphatasia","volume":"366","author":"Whyte","year":"2012","journal-title":"N Engl J Med"},{"issue":"21","key":"2025101705020294400_lvaf064-B89","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"2025101705020294400_lvaf064-B90","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1210\/clinem\/dgad657","article-title":"Management of RANKL-mediated disorders with denosumab in children and adolescents: a global expert guidance document","volume":"109","author":"Vanderniet","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025101705020294400_lvaf064-B91","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/17446651.2024.2390416","article-title":"Progress in managing children with achondroplasia","volume":"19","author":"Taylor-Miller","year":"2024","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"10","key":"2025101705020294400_lvaf064-B92","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1517\/21678707.2015.1083853","article-title":"New therapeutic targets in rare genetic skeletal diseases","volume":"3","author":"Briggs","year":"2015","journal-title":"Expert Opin Orphan Drugs"},{"issue":"4","key":"2025101705020294400_lvaf064-B93","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/diseases8040042","article-title":"Precision medicine in rare diseases","volume":"8","author":"Villalon-Garcia","year":"2020","journal-title":"Diseases"},{"issue":"22","key":"2025101705020294400_lvaf064-B94","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1093\/hmg\/ddy253","article-title":"Carbamazepine reduces disease severity in a mouse model of metaphyseal chondrodysplasia type Schmid caused by a premature stop codon (Y632X) in the Col10a1 gene","volume":"27","author":"Forouhan","year":"2018","journal-title":"Hum Mol Genet"},{"key":"2025101705020294400_lvaf064-B95","doi-asserted-by":"publisher","first-page":"645593","DOI":"10.3389\/fcell.2021.645593","article-title":"Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype","volume":"9","author":"Kumari","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2025101705020294400_lvaf064-B96","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bone.2019.01.015","article-title":"Cellular senescence in bone","volume":"121","author":"Farr","year":"2019","journal-title":"Bone"},{"key":"2025101705020294400_lvaf064-B97","doi-asserted-by":"publisher","first-page":"111565","DOI":"10.1016\/j.mad.2021.111565","article-title":"The role of senolytics in osteoporosis and other skeletal pathologies","volume":"199","author":"Doolittle","year":"2021","journal-title":"Mech Ageing Dev"},{"issue":"5","key":"2025101705020294400_lvaf064-B98","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41574-020-0335-y","article-title":"The role of cellular senescence in ageing and endocrine disease","volume":"16","author":"Khosla","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"2025101705020294400_lvaf064-B99","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/nm.4385","article-title":"Targeting cellular senescence prevents age-related bone loss in mice","volume":"23","author":"Farr","year":"2017","journal-title":"Nat Med"},{"key":"2025101705020294400_lvaf064-B100","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fcell.2020.00354","article-title":"The senolytic drug navitoclax (ABT-263) causes trabecular bone loss and impaired osteoprogenitor function in aged mice","volume":"8","author":"Sharma","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2025101705020294400_lvaf064-B101","doi-asserted-by":"publisher","first-page":"20S","DOI":"10.1097\/PRS.0000000000009669","article-title":"Targeting cellular senescence for age-related diseases: path to clinical translation","volume":"150","author":"Wyles","year":"2022","journal-title":"Plast Reconstr Surg"},{"issue":"25","key":"2025101705020294400_lvaf064-B102","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMcp1106636","article-title":"Clinical practice","volume":"365","author":"Marcocci","year":"2011","journal-title":"Primary hyperparathyroidism. N Engl J Med"},{"issue":"11","key":"2025101705020294400_lvaf064-B103","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1056\/NEJMcp1714213","article-title":"Primary hyperparathyroidism","volume":"379","author":"Insogna","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"2025101705020294400_lvaf064-B104","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jocd.2012.12.001","article-title":"Normocalcemic primary hyperparathyroidism","volume":"16","author":"Cusano","year":"2013","journal-title":"J Clin Densitom"},{"issue":"11","key":"2025101705020294400_lvaf064-B105","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1210\/jc.2017-01080","article-title":"Sex difference in the clinical presentation of primary hyperparathyroidism: influence of menopausal Status","volume":"102","author":"Castellano","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025101705020294400_lvaf064-B106","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/ejendo\/lvad144","article-title":"Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study","volume":"189","author":"Boros","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"2025101705020294400_lvaf064-B107","doi-asserted-by":"publisher","first-page":"115402","DOI":"10.1016\/j.bone.2020.115402","article-title":"Loss of BMP signaling mediated by BMPR1A in osteoblasts leads to differential bone phenotypes in mice depending on anatomical location of the bones","volume":"137","author":"Zhang","year":"2020","journal-title":"Bone"},{"issue":"1","key":"2025101705020294400_lvaf064-B108","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41413-023-00306-4","article-title":"Insights and implications of sexual dimorphism in osteoporosis","volume":"12","author":"Zhang","year":"2024","journal-title":"Bone Res"},{"issue":"10","key":"2025101705020294400_lvaf064-B109","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1210\/en.2018-00601","article-title":"FSH, bone mass, body fat, and biological aging","volume":"159","author":"Zaidi","year":"2018","journal-title":"Endocrinology"},{"issue":"3","key":"2025101705020294400_lvaf064-B110","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3109\/13685538.2013.875991","article-title":"FRAX calculator and garvan nomogram in male osteoporotic population","volume":"17","author":"Pluskiewicz","year":"2014","journal-title":"Aging Male"},{"issue":"4","key":"2025101705020294400_lvaf064-B111","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S2213-8587(22)00012-2","article-title":"Osteoporosis in men","volume":"10","author":"Vilaca","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2025101705020294400_lvaf064-B112","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1359\/JBMR.041133","article-title":"Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures","volume":"20","author":"Jiang","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2025101705020294400_lvaf064-B113","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1210\/jc.2004-1568","article-title":"Hip fracture in women without osteoporosis","volume":"90","author":"Wainwright","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025101705020294400_lvaf064-B114","doi-asserted-by":"publisher","first-page":"101775","DOI":"10.1016\/j.berh.2022.101775","article-title":"Risk assessment tools for osteoporosis and fractures in 2022","volume":"36","author":"Carey","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"9","key":"2025101705020294400_lvaf064-B115","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00198-023-06817-4","article-title":"Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO), and the international osteoporosis foundation (IOF) under the auspices of WHO collaborating center for epidemiology of musculoskeletal health and aging","volume":"34","author":"Shevroja","year":"2023","journal-title":"Osteoporos Int"},{"issue":"3","key":"2025101705020294400_lvaf064-B116","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jocd.2018.11.004","article-title":"DXA-Based 3D analysis of the cortical and trabecular bone of hip fracture postmenopausal women: a case-control study","volume":"23","author":"Humbert","year":"2020","journal-title":"J Clin Densitom"},{"issue":"12","key":"2025101705020294400_lvaf064-B117","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.4158\/EP161714.OR","article-title":"Adding Vfa to Dxa identifies fracture risk in a way not duplicated by other measures","volume":"23","author":"Ginther","year":"2017","journal-title":"Endocr Pract"},{"issue":"5","key":"2025101705020294400_lvaf064-B118","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/CORR.0000000000001648","article-title":"CORR insights(R): a cam morphology develops in the early phase of the final growth spurt in adolescent ice hockey players: results of a prospective MRI-based study","volume":"479","author":"Zhang","year":"2021","journal-title":"Clin Orthop Relat Res"},{"key":"2025101705020294400_lvaf064-B119","doi-asserted-by":"publisher","first-page":"109568","DOI":"10.1016\/j.ejrad.2021.109568","article-title":"Opportunistic screening for osteoporosis and osteopenia by routine computed tomography scan: a heterogeneous, multiethnic, middle-eastern population validation study","volume":"136","author":"Cohen","year":"2021","journal-title":"Eur J Radiol"},{"issue":"3","key":"2025101705020294400_lvaf064-B120","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/jbmr.3901","article-title":"HR-pQCT measures of bone microarchitecture predict fracture: systematic review and meta-analysis","volume":"35","author":"Mikolajewicz","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2025101705020294400_lvaf064-B121","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1002\/jbmr.4449","article-title":"Best performance parameters of HR-pQCT to predict fragility fracture: systematic review and meta-analysis","volume":"36","author":"Cheung","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2025101705020294400_lvaf064-B122","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/jbmr.4342","article-title":"Bone radiomics score derived from DXA hip images enhances hip fracture prediction in older women","volume":"36","author":"Hong","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025101705020294400_lvaf064-B123","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/jmri.27260","article-title":"MRI-based quantitative osteoporosis imaging at the spine and femur","volume":"54","author":"Sollmann","year":"2021","journal-title":"J Magn Reson Imaging"},{"key":"2025101705020294400_lvaf064-B124","doi-asserted-by":"publisher","first-page":"115786","DOI":"10.1016\/j.bone.2020.115786","article-title":"Radiofrequency Echographic Multi Spectrometry (REMS) for the diagnosis of osteoporosis in a European multicenter clinical context","volume":"143","author":"Cortet","year":"2021","journal-title":"Bone"},{"issue":"7","key":"2025101705020294400_lvaf064-B125","doi-asserted-by":"publisher","first-page":"e220034","DOI":"10.1530\/EC-22-0034","article-title":"3T-MRI-based age, sex and site-specific markers of musculoskeletal health in healthy children and young adults","volume":"11","author":"Elsharkasi","year":"2022","journal-title":"Endocr Connect"},{"key":"2025101705020294400_lvaf064-B126","doi-asserted-by":"publisher","first-page":"815835","DOI":"10.3389\/fendo.2022.815835","article-title":"Gender- and age-associated differences in bone marrow adipose tissue and bone marrow fat unsaturation throughout the skeleton, quantified using chemical shift encoding-based water-fat MRI","volume":"13","author":"Beekman","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025101705020294400_lvaf064-B127","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fendo.2020.00015","article-title":"Added value of impact microindentation in the evaluation of bone fragility: a systematic review of the literature","volume":"11","author":"Schoeb","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2025101705020294400_lvaf064-B128","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/ckj\/sfac219","article-title":"MicroRNAs: emerging biomarkers and therapeutic targets of bone fragility in chronic kidney disease","volume":"16","author":"Smout","year":"2022","journal-title":"Clin Kidney J"},{"issue":"4","key":"2025101705020294400_lvaf064-B129","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/bios10040042","article-title":"Advances in sensing technologies for monitoring of bone health","volume":"10","author":"Rani","year":"2020","journal-title":"Biosensors (Basel)"},{"issue":"3","key":"2025101705020294400_lvaf064-B130","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/03008207.2022.2041002","article-title":"Implantable biosensors for musculoskeletal health","volume":"63","author":"Nash","year":"2022","journal-title":"Connect Tissue Res"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/Supplement_2\/ii23\/64633666\/lvaf064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/Supplement_2\/ii23\/64633666\/lvaf064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:02:08Z","timestamp":1760691728000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/193\/Supplement_2\/ii23\/8281956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":130,"journal-issue":{"issue":"Supplement_2","published-print":{"date-parts":[[2025,10,17]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf064","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,10]]}}}